European guideline implementation
European guideline implementation has been studied in 1 paper since 2026: 1 observational study in people; 1 in the past year. The newest paper, Sep 7, 2026: “Nationwide LDL-C goal attainment in high-risk and very-high-risk patients in Denmark: real-world lipid management and simulated impact of guideline implementation”.
1 paper studies it2 findingsUpdated
See all 1 papers on european guideline implementation
- Humans1
What did studies of european guideline implementation find?
2Studies of european guideline implementation measured 2 outcomes: cardiovascular death and LDL-C goal attainment.
Cardiovascular death
downin silico1
1 study
Cardiovascular death
downin silico1
European guideline implementation prevents cardiovascular death in silico (additional to Danish guideline implementation, simulated) (67 additional cardiovascular deaths annually).
“Implementation of the European guideline would avert an additional 179 strokes, 156 myocardial infarctions, 166 revascularisations and 67 cardiovascular deaths”
In silicoadditional to Danish guideline implementation, simulated
Open heart
LDL-C goal attainment
upin silico1
1 study
LDL-C goal attainment
upin silico1
European guideline implementation increases LDL-C goal attainment in silico (simulated optimal implementation) (to 75.8% primary and 96.8% secondary prevention).
“and to 75.8% (primary) and 96.8% (secondary) under the European guideline”
In silicosimulated optimal implementation
Open heart